Analyst Ratings for Recro Pharma (REPH)

REPH Rating Summary

  |   Expand Research on REPH
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8.3 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/12/2021 William Blair John Kreger III New Coverage Outperform
(N/A)		 N/A
(N/A)		 1.90
(2.09)		 10% Details
1/4/2021 Craig-Hallum Matt Hewitt New Coverage Buy
(N/A)		 6.00
(N/A)		 2.85
(2.09)		 -26.67% Details